New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
08:30 EDTATRCAtriCure posted outstanding Q2 results, says Canaccord
Canaccord said Atricure posted outstanding Q2 results, citing its growth trajectory, its integration of the Estech acquisition, and its investments in education and product development. The firm feels Atricure is undervalued and reiterates its Buy rating and $26 price target on the shares.
News For ATRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:49 EDTATRCAtriCure remains a favorite small-cap stock for 2015, says Canaccord
Canaccord said AtriCure remains one of its favorite small-cap stock picks for 2015 following its inaugural analyst day. The firm sees accelerating growth and expanding gross margins. Canaccord reiterated its Buy rating and raised its price target to $28 from $26 on AtriCure shares.
March 20, 2015
09:21 EDTATRCAtriCure to host analyst/investor meeting
Analyst/Investor Meeting to be held in New York on March 24 at 8 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use